New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Malpractice trends involving active surveillance across cancers

Malpractice trends involving active surveillance across cancers

by Cedars-Sinai Medical CenterCredit: CC0 Public DomainActive surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly
Oncology March 30,2024
Malpractice trends involving active surveillance across cancers

Malpractice trends involving active surveillance across cancers

by Cedars-Sinai Medical CenterCredit: CC0 Public DomainActive surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly
Oncology March 30,2024
Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

by Greg Glasgow,CU Anschutz Medical CampusCredit: CC0 Public DomainThe results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer
Oncology March 30,2024
Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

by Greg Glasgow,CU Anschutz Medical CampusCredit: CC0 Public DomainThe results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer
Oncology March 30,2024
Predicting oral cancer-related mortality among adults using machine learning approach

Predicting oral cancer-related mortality among adults using machine learning approach

by International Association for Dental, Oral, and Craniofacial ResearchCredit: Unsplash/CC0 Public DomainA study aiming to predict oral cancer-related mortality among adults in the United States and
Oncology March 30,2024
Predicting oral cancer-related mortality among adults using machine learning approach

Predicting oral cancer-related mortality among adults using machine learning approach

by International Association for Dental, Oral, and Craniofacial ResearchCredit: Unsplash/CC0 Public DomainA study aiming to predict oral cancer-related mortality among adults in the United States and
Oncology March 30,2024
Researchers create new tool for assessing risk of kidney injury after chemotherapy

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for
Oncology March 30,2024
Researchers create new tool for assessing risk of kidney injury after chemotherapy

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for
Oncology March 30,2024
Assessing breast cancer risk

Assessing breast cancer risk

by Mayo ClinicCredit: Unsplash/CC0 Public DomainThe genetic risk of breast cancer has been in the news lately. Researchers at the Mayo Clinic Comprehensive Cancer Center are working toward pinpoi
Oncology March 30,2024
Assessing breast cancer risk

Assessing breast cancer risk

by Mayo ClinicCredit: Unsplash/CC0 Public DomainThe genetic risk of breast cancer has been in the news lately. Researchers at the Mayo Clinic Comprehensive Cancer Center are working toward pinpoi
Oncology March 30,2024
Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G
Oncology March 30,2024
Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G
Oncology March 30,2024
Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op
Oncology March 30,2024
Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op
Oncology March 30,2024
AI-driven attention mechanisms aid in streamlining cancer pathology reporting

AI-driven attention mechanisms aid in streamlining cancer pathology reporting

by Mark Alewine,Oak Ridge National LaboratoryCredit: Pixabay/CC0 Public DomainArtificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.In partn
Oncology March 30,2024
AI-driven attention mechanisms aid in streamlining cancer pathology reporting

AI-driven attention mechanisms aid in streamlining cancer pathology reporting

by Mark Alewine,Oak Ridge National LaboratoryCredit: Pixabay/CC0 Public DomainArtificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.In partn
Oncology March 30,2024
Heading off financial harms in cancer patients

Heading off financial harms in cancer patients

by Columbia UniversityCredit: Pixabay/CC0 Public DomainA screening tool can quickly identify cancer patients at risk of financial toxicity, new findings from Columbia Nursing researchers show.Mos
Oncology March 30,2024
Heading off financial harms in cancer patients

Heading off financial harms in cancer patients

by Columbia UniversityCredit: Pixabay/CC0 Public DomainA screening tool can quickly identify cancer patients at risk of financial toxicity, new findings from Columbia Nursing researchers show.Mos
Oncology March 30,2024
Antibody eradicates leukemia stem cells

Antibody eradicates leukemia stem cells

by Sarah C.p. Williams,University of California, Los AngelesBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaThe introduction of the drug imat
Oncology March 30,2024
Antibody eradicates leukemia stem cells

Antibody eradicates leukemia stem cells

by Sarah C.p. Williams,University of California, Los AngelesBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaThe introduction of the drug imat
Oncology March 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com